• Satellos Announces Dosing of First Participant in Phase 1 Clinical Study of SAT-3247 | Morningstar

    المصدر: Buzz FX / 18 سبتمبر 2024 08:34:14   America/New_York


    [Business Wire](/news/business-wire) Satellos Announces Dosing of First Participant in Phase 1 Clinical Study of SAT-3247 Satellos Announces Dosing of First Participant in Phase 1 Clinical Study of SAT-3247 - The first healthy volunteer has
    Read more...
شارك على،